Common features of neurodegenerative disease: exploring the brain-eye connection and beyond (Part 1): the 2021 pre-symposium of the 15th international conference on Alzheimer's and Parkinson's diseases

• Type of Material: Article
• Authors: Sharyn L Rossi, BrightFocus Foundation; Preeti Subramanian, BrightFocus Foundation; Guojun Bu, Mayo Clinic, Jacksonville; Adriana Di Polo, University of Montreal; Todd Golde, Emory University; Diane E Bovenkamp, BrightFocus Foundation
• Language: English
• Date: 2022-10-31
• Publisher: BMC
• Publication Version: Final Published Version
• Copyright Statement: © The Author(s) 2022
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1186/s13024-022-00570-8
• Title of Journal or Parent Work: MOLECULAR NEURODEGENERATION
• Volume: 17
• Issue: 1
• Start Page: 68
• End Page: 68
• Grant/Funding Information: Thank you to the donors of BrightFocus Foundation for helping to fund the Common Features of Neurodegenerative Diseases: Exploring the Eye-Brain Connection and Beyond meeting, which may lead to innovative discoveries and solutions towards preventions, treatments and cures for Alzheimer’s disease and related dementias, glaucoma, and macular degeneration.
• Keywords: microglia; resistance; Neurosciences & Neurology; brain reserve; Alzheimer's disease (AD) and related dementias; neurodegeneration; inflammation; glaucoma; cellular senescence; comorbid; biomarker; Neurosciences; cognitive reserve; senolytics; age-related macular degeneration (AMD); astrocytes; Life Sciences & Biomedicine; compensation; resilience; geroscience; Science & Technology; longevity; retinal ganglion cells (RGC)
• Research Categories: Health Sciences, Pharmacology

Abstract

BrightFocus Foundation sponsored the third iteration of the “Common Features of Neurodegenerative Disease: Exploring the Brain-Eye Connection and Beyond” pre-conference symposium that preceded the 15th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2021). Part 1 of the meeting report was previously published in Molecular Neurodegeneration. This completes the description of the meeting with Part 2.